Primary |
Product Used For Unknown Indication |
47.1% |
Hypertension |
18.6% |
Renal Transplant |
4.3% |
Abnormal Behaviour |
2.9% |
Parkinson's Disease |
2.9% |
Type 2 Diabetes Mellitus |
2.9% |
Urinary Tract Infection |
2.9% |
Angina Pectoris |
1.4% |
Anxiety |
1.4% |
Arrhythmia |
1.4% |
Atrial Fibrillation |
1.4% |
Bipolar I Disorder |
1.4% |
Blood Pressure Increased |
1.4% |
Cardiac Failure |
1.4% |
Cardiac Failure Congestive |
1.4% |
Cardiomegaly |
1.4% |
Cerebrovascular Accident |
1.4% |
Depression |
1.4% |
Diuretic Therapy |
1.4% |
Drug Eruption |
1.4% |
|
Vomiting |
12.0% |
Interstitial Lung Disease |
8.0% |
Syncope |
8.0% |
Urinary Tract Infection |
8.0% |
Acute Generalised Exanthematous Pustulosis |
4.0% |
Angina Pectoris |
4.0% |
Atrioventricular Block Complete |
4.0% |
Connective Tissue Disorder |
4.0% |
Headache |
4.0% |
Heart Rate Increased |
4.0% |
Hepatitis |
4.0% |
Laryngeal Oedema |
4.0% |
Loss Of Consciousness |
4.0% |
Lymphoedema |
4.0% |
Oedema |
4.0% |
Pain In Extremity |
4.0% |
Pharmaceutical Product Counterfeit |
4.0% |
Pregnancy |
4.0% |
Presyncope |
4.0% |
Sedation |
4.0% |
|
Secondary |
Product Used For Unknown Indication |
33.3% |
Drug Use For Unknown Indication |
9.2% |
Hypertension |
9.2% |
Depression |
5.8% |
Blood Pressure Increased |
5.0% |
Atrial Fibrillation |
4.2% |
Ill-defined Disorder |
4.2% |
Cardiac Failure |
3.3% |
Cardiovascular Disorder |
3.3% |
Intentional Overdose |
3.3% |
Pain |
3.3% |
Cardiac Disorder |
2.5% |
Essential Hypertension |
2.5% |
Arrhythmia |
1.7% |
Dyslipidaemia |
1.7% |
Myocardial Infarction |
1.7% |
Myocardial Ischaemia |
1.7% |
Partial Seizures |
1.7% |
Rheumatoid Arthritis |
1.7% |
Atrial Tachycardia |
0.8% |
|
Angioedema |
18.5% |
Suicidal Ideation |
7.4% |
Tremor |
7.4% |
Vomiting |
7.4% |
Delirium |
3.7% |
Drug Interaction |
3.7% |
Gait Disturbance |
3.7% |
Hallucination |
3.7% |
Hypertension |
3.7% |
Hypovolaemia |
3.7% |
Intentional Overdose |
3.7% |
Joint Dislocation |
3.7% |
Persecutory Delusion |
3.7% |
Photosensitivity Reaction |
3.7% |
Quality Of Life Decreased |
3.7% |
Rash Maculo-papular |
3.7% |
Rectal Haemorrhage |
3.7% |
Renal Aplasia |
3.7% |
Renal Failure Acute |
3.7% |
Respiratory Distress |
3.7% |
|
Concomitant |
Product Used For Unknown Indication |
37.8% |
Hypertension |
10.0% |
Drug Use For Unknown Indication |
6.4% |
Type 2 Diabetes Mellitus |
5.2% |
Prophylaxis |
4.8% |
Depression |
4.4% |
Atrial Fibrillation |
4.0% |
Acute Myocardial Infarction |
2.8% |
Chronic Lymphocytic Leukaemia |
2.8% |
Colon Cancer |
2.8% |
Parkinson's Disease |
2.8% |
Anticoagulant Therapy |
2.0% |
Cardiac Failure |
2.0% |
Gout |
2.0% |
Pain |
2.0% |
Diabetes Mellitus |
1.6% |
Gastrooesophageal Reflux Disease |
1.6% |
Hyperlipidaemia |
1.6% |
Lower Respiratory Tract Infection |
1.6% |
Non-small Cell Lung Cancer |
1.6% |
|
Renal Failure Acute |
9.4% |
Weight Decreased |
9.4% |
Vomiting |
8.2% |
International Normalised Ratio Increased |
5.9% |
Paraesthesia |
5.9% |
Tremor |
5.9% |
Pain In Extremity |
4.7% |
Renal Impairment |
4.7% |
Sepsis |
4.7% |
Somnolence |
4.7% |
Wrong Drug Administered |
4.7% |
Gastrointestinal Haemorrhage |
3.5% |
Hypomagnesaemia |
3.5% |
Hyponatraemia |
3.5% |
Lipase Increased |
3.5% |
Lower Respiratory Tract Infection |
3.5% |
Myalgia |
3.5% |
Rash |
3.5% |
Restless Legs Syndrome |
3.5% |
Road Traffic Accident |
3.5% |
|